In the female group, complement and coagulation cascades, ECM-receptor interaction, and IL-17 signaling pathways were significantly influenced by delayed treatment of PARP-1 inhibitor in the ischemic stroke (Figure 2D). This evidence concerns the gene IL17A and ischemic stroke.